Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia: First clinical experiences and relation with cellular sensitivity to single agent calicheamicin [5]

Ch M. Zwaan; D. Reinhardt; H. Jürgens; D. R. Huismans; K. Hählen; O. P. Smith; A. Biondi; E. R. van Wering; J. Feingold; G. J.L. Kaspers

doi:10.1038/sj.leu.2402749

Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia: First clinical experiences and relation with cellular sensitivity to single agent calicheamicin [5]

Ch M. Zwaan
, D. Reinhardt
, H. Jürgens
, D. R. Huismans
, K. Hählen
, O. P. Smith
, A. Biondi
, E. R. van Wering
, J. Feingold
, G. J.L. Kaspers

Research output: Contribution to journal › Letter › peer-review

61 Citations (Scopus)

Original language	English
Pages (from-to)	468-470
Number of pages	3
Journal	Leukemia
Volume	17
Issue number	2
DOIs	https://doi.org/10.1038/sj.leu.2402749
Publication status	Published - 1 Feb 2003
Externally published	Yes

Access to Document

10.1038/sj.leu.2402749

Cite this

Zwaan, C. M., Reinhardt, D., Jürgens, H., Huismans, D. R., Hählen, K., Smith, O. P., Biondi, A., van Wering, E. R., Feingold, J., & Kaspers, G. J. L. (2003). Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia: First clinical experiences and relation with cellular sensitivity to single agent calicheamicin [5]. Leukemia, 17(2), 468-470. https://doi.org/10.1038/sj.leu.2402749

@article{f997a13eb46b49c88c2fb63c0b7155ee,

title = "Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia: First clinical experiences and relation with cellular sensitivity to single agent calicheamicin [5]",

author = "Zwaan, \{Ch M.\} and D. Reinhardt and H. J{\"u}rgens and Huismans, \{D. R.\} and K. H{\"a}hlen and Smith, \{O. P.\} and A. Biondi and \{van Wering\}, \{E. R.\} and J. Feingold and Kaspers, \{G. J.L.\}",

year = "2003",

month = feb,

day = "1",

doi = "10.1038/sj.leu.2402749",

language = "English",

volume = "17",

pages = "468--470",

journal = "Leukemia",

issn = "0887-6924",

publisher = "Springer Nature",

number = "2",

}

Zwaan, CM, Reinhardt, D, Jürgens, H, Huismans, DR, Hählen, K, Smith, OP, Biondi, A, van Wering, ER, Feingold, J & Kaspers, GJL 2003, 'Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia: First clinical experiences and relation with cellular sensitivity to single agent calicheamicin [5]', Leukemia, vol. 17, no. 2, pp. 468-470. https://doi.org/10.1038/sj.leu.2402749

TY - JOUR

T1 - Gemtuzumab ozogamicin in pediatric CD33-positive acute lymphoblastic leukemia

T2 - First clinical experiences and relation with cellular sensitivity to single agent calicheamicin [5]

AU - Zwaan, Ch M.

AU - Reinhardt, D.

AU - Jürgens, H.

AU - Huismans, D. R.

AU - Hählen, K.

AU - Smith, O. P.

AU - Biondi, A.

AU - van Wering, E. R.

AU - Feingold, J.

AU - Kaspers, G. J.L.

PY - 2003/2/1

Y1 - 2003/2/1

UR - https://www.scopus.com/pages/publications/0037326082

U2 - 10.1038/sj.leu.2402749

DO - 10.1038/sj.leu.2402749

M3 - Letter

C2 - 12592351

AN - SCOPUS:0037326082

SN - 0887-6924

VL - 17

SP - 468

EP - 470

JO - Leukemia

JF - Leukemia

IS - 2

ER -